Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Market Size and Research: Evidence from the Pharmaceutical Industry
by
Higgins, Matthew J
, Gaessler, Fabian
, Byrski, Dennis
in
Medicare
/ Pharmaceutical industry
2021
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Market Size and Research: Evidence from the Pharmaceutical Industry
by
Higgins, Matthew J
, Gaessler, Fabian
, Byrski, Dennis
in
Medicare
/ Pharmaceutical industry
2021
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Market Size and Research: Evidence from the Pharmaceutical Industry
Paper
Market Size and Research: Evidence from the Pharmaceutical Industry
2021
Request Book From Autostore
and Choose the Collection Method
Overview
Prior literature has established a link between changes in market size and pharmaceutical innovation; whether a link exists with scientific research remains an open question. If upstream research is not responsive to these changes, the kinds of scientific discoveries that flow into future drug development could be disconnected from downstream demand. We explore this question by exploiting the effects of quasi-experimental variation in market size introduced by Medicare Part D. We find no causal relationship between market size and biomedical research in the decade following the implementation of Medicare Part D. While many factors have been shown to motivate scientists to conduct research, this result suggests that changes in market size provide no such incentive. We do find, however, limited support for a response by corporate scientists conducting applied research. Implications for pharmaceutical innovation policy are discussed.
Publisher
Federal Reserve Bank of St. Louis
Subject
This website uses cookies to ensure you get the best experience on our website.